These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4268324)

  • 1. Evaluation of a cell-mediated cytotoxicity assay utilizing 125 iododeoxyuridine-labeled tissue-culture target cells.
    Oldham RK; Siwarski D; McCoy JL; Plata EJ; Herberman RB
    Natl Cancer Inst Monogr; 1973 Jun; 37():49-58. PubMed ID: 4268324
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of cell-mediated cytotoxic reactivity against tumor associated antigens with 125I-iododeoxyuridine labeled target cells.
    Oldham RK; Herberman RB
    J Immunol; 1973 Dec; 111(6):862-71. PubMed ID: 4750872
    [No Abstract]   [Full Text] [Related]  

  • 3. Cell-mediated cytotoxicity: an assay using 125 I-iododeoxyuridine-labeled target cells.
    Cohen AM; Burdick JF; Ketcham AS
    J Immunol; 1971 Sep; 107(3):895-8. PubMed ID: 5572095
    [No Abstract]   [Full Text] [Related]  

  • 4. Cell-mediated immunity to Friend virus-induced leukemia. I. Modification of 125IUdR release cytotoxicity assay for use with suspension target cells.
    Ting C-C ; Bushar GS; Rodrigues D; Herberman RB
    J Immunol; 1975 Nov; 115(5):1351-6. PubMed ID: 170343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Problems in the clinical use of the microcytotoxicity assay for measuring cell-mediated immunity to tumor cells.
    Heppner G; Henry E; Stolbach L; Cummings F; McDonough E; Calabresi P
    Cancer Res; 1975 Aug; 35(8):1931-7. PubMed ID: 1149017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural cytotoxic reactivity of rat lymphocytes against gross virus-induced tumor cell lines as measured by [125I]iododeoxyuridine and tritiated proline microcytotoxicity assays.
    Oldham RK; Ortaldo JR; Herberman RB
    Cancer Res; 1977 Dec; 37(12):4467-74. PubMed ID: 922735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell- and antibody-mediated immune reactions of patients to cultured cells of breast carcinoma.
    Sinkovics JG; Reeves WJ; Cabiness JR
    J Natl Cancer Inst; 1972 Apr; 48(4):1145-9. PubMed ID: 5023675
    [No Abstract]   [Full Text] [Related]  

  • 8. Immune responses to virus induced experimental leukemia and to human leukemia.
    Herberman RB
    Johns Hopkins Med J Suppl; 1974; 3():3-14. PubMed ID: 4371287
    [No Abstract]   [Full Text] [Related]  

  • 9. Suppression of Gross leukemia cell-surface antigens: a kind of antigenic modulation.
    Aoki T; Johnson PA
    J Natl Cancer Inst; 1972 Jul; 49(1):183-92. PubMed ID: 5037434
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of an in vitro microcytotoxicity test to assess human tumor-specific cell-mediated immunity and its serum-mediated abrogation.
    Levy NL
    Natl Cancer Inst Monogr; 1973 Jun; 37():85-92. PubMed ID: 4576707
    [No Abstract]   [Full Text] [Related]  

  • 11. Thymus-derived lymphocytes as effectors of cell-mediated immunity to syngeneic and allogeneic transplants in the rat.
    Tucker DF; Dennert G; Lennox ES
    J Immunol; 1974 Oct; 113(4):1302-12. PubMed ID: 4547337
    [No Abstract]   [Full Text] [Related]  

  • 12. Induction of lymphocyte-mediated cytotoxicity against allogeneic tumor cells by concanavalin A in vivo.
    Anaclerio A; Waterfield JD; Möller G
    J Immunol; 1974 Sep; 113(3):870-5. PubMed ID: 4413847
    [No Abstract]   [Full Text] [Related]  

  • 13. Embryonic antigens in tumor immunity.
    Della Porta G
    Johns Hopkins Med J Suppl; 1974; 3():279-87. PubMed ID: 4138923
    [No Abstract]   [Full Text] [Related]  

  • 14. Specific antibody activation of lymphocytes for cell-mediated cytotoxicity against cultured target cells.
    Takasugi M; Kinoshita K
    J Natl Cancer Inst; 1974 Dec; 53(6):1539-44. PubMed ID: 4474407
    [No Abstract]   [Full Text] [Related]  

  • 15. Enzymatic enhancement of cell-mediated cytotoxicity and antibody-dependent cell cytotoxicity.
    Kedar E; Otiz de Landazuri M; Fahey JL
    J Immunol; 1974 Jan; 112(1):26-36. PubMed ID: 4812174
    [No Abstract]   [Full Text] [Related]  

  • 16. Prelabeling target cells with 3 H-proline as a method for studying lymphocyte cytotoxicity.
    Bean MA; Pees H; Rosen G; Oettgen HF
    Natl Cancer Inst Monogr; 1973 Jun; 37():41-8. PubMed ID: 4713785
    [No Abstract]   [Full Text] [Related]  

  • 17. Problems in the use of in vitro assays for monitoring cell-mediated immunity in cancer patients.
    de Vries JE
    Bull Cancer; 1976; 63(2):279-86. PubMed ID: 791397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on specificity of cell-mediated immunity to human tumors.
    Takasugi M; Mickey MR; Terasaki PI
    J Natl Cancer Inst; 1974 Dec; 53(6):1527-38. PubMed ID: 4140237
    [No Abstract]   [Full Text] [Related]  

  • 19. Functional efficiency of antitumor cytotoxic lymphoid cells.
    Wunderlich JR; Martin WJ; Macdonald J
    Isr J Med Sci; 1973 Mar; 9(3):317-23. PubMed ID: 4710039
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies of inhibition of tumour cell DNA synthesis by immune cells in Gross virus induced leukemia.
    Finklestein JZ; Byfield J; Tittle K; Imagawa DT
    Rev Eur Etud Clin Biol; 1972 Mar; 17(3):287-92. PubMed ID: 5053619
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.